NATIONAL HEALTHCARE CORP (NHC)
Data as of , from SEC Form 4 filings.
See up to 3 months of NHC. The 7-day demo opens the 1M and 3M ranges and puts NHC on your watchlist.
Start 7-day demoLatest NHC insider trades
About NATIONAL HEALTHCARE CORP (NHC)
NATIONAL HEALTHCARE CORP files with the SEC under CIK 0001047335 and is classified as skilled nursing care facilities. We track it alongside the rest of the Health Care sector.
NHC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 15 | 24,645 | $5.58M |
| Grant or award | 1 | 4,691 | |
| Option exercise | 4 | 15,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NHC insider transactions (Form 4)
5689 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Vicki L. Dodson - Officer | Open-market sale | Shares of Common Stock held in my name | 4,834 | $225.00 | $1.09M | |
| Open-market sale | Common Stock | 571 | $222.73 footnote F1 | $127K | ||
| Open-market sale | Common Stock | 789 | $223.78 footnote F2 | $177K | ||
| Open-market sale | Common Stock | 1,291 | $225.09 footnote F3 | $291K | ||
| Open-market sale | Common Stock | 68 | $225.59 footnote F4 | $15K | ||
| ||||||
| Brian F. Kidd - Officer | Open-market sale | Common Stock | 6,813 | $225.70 | $1.54M | |
| Open-market sale | Common Stock | 1,000 | $221.21 | $221K | ||
| Open-market sale | Common Stock | 1,000 | $222.11 | $222K | ||
| Open-market sale | Common Stock | 1,000 | $226.00 | $226K | ||
| Open-market sale | Common Stock | 1,000 | $237.18 | $237K | ||
| Open-market sale | Common Stock | 1,000 | $237.00 | $237K | ||
| Open-market sale | Common Stock | 1,000 | $227.00 | $227K | ||
| Open-market sale | Common Stock | 1,000 | $222.50 | $223K | ||
| Open-market sale | Common Stock | 1,779 | $225.42 | $401K | ||
| Option exercise | Common Stock | 6,479 footnote F1 | $171.42 | $1.11M | ||
| Grant or award | Common Stock | 4,691 footnote F2 | $236.75 | $1.11M | ||
| Option exercise | Option to Purchase Common Stock [2026 Grant] | 6,479 footnote F1 | $0.00 | - | ||
| ||||||
| Open-market sale | Common Stock | 1,500 | $237.08 | $356K | ||
| Option exercise | Common Stock | 1,021 footnote F1 | $171.42 | $175K | ||
| Option exercise | Option to Purchase Common Stock [2026 Grant] | 1,021 footnote F1 | $0.00 | - | ||
| ||||||
| Emil E. Hassan - Director | Open-market sale | Shares of Common Stock | 5,937 | $200.00 | $1.19M | |
| Brian F. Kidd - Officer | Gift | Common Stock | 500 | $0.00 | - | |
| Emil E. Hassan - Director | Open-market sale | Shares of Common Stock | 1,563 | $199.98 | $313K | |
| Robert G. Adams - Director | Gift | Shares of Common Stock - Trust I | 4,000 | $0.00 | - | |
| Robert G. Adams - Director | Option exercise | Option to Purchase Common Stock [2022 Grant] | 4,000 footnote F1 | $0.00 | - | |
| Robert G. Adams - Director | Option exercise | Shares of Common Stock - Trust I | 4,000 footnote F1 | $69.19 | $277K | |
| ||||||
| Lisa Piercey - Director | Open-market purchase | Common Stock | 949 | $184.26 | $175K | |
| Option exercise | Common Stock | 4,000 footnote F1 | $94.10 | $376K | ||
| Tax withholding / forfeiture | Common Stock | 2,739 footnote F2 | $196.00 | $537K | ||
| Option exercise | Option to Purchase Common Stock | 4,000 footnote F1 | $0.00 | - | ||
| ||||||
| Richard F. Laroche Jr. - Director | Open-market sale | Common Stock - Held in my name or my wife's name | 7,500 | $195.14 | $1.46M | |
| Gift | Common Stock | 26 | $0.00 | - | ||
| Timothy J. Shelly - Officer | Open-market sale | Common Stock | 1,853 | $197.22 | $365K | |
| Option exercise | Common Stock | 5,000 footnote F1 | $94.10 | $471K | ||
| Option exercise | Common Stock | 1,000 footnote F2 | $90.62 | $91K | ||
| Tax withholding / forfeiture | Common Stock | 4,492 footnote F3 | $197.96 | $889K | ||
| Option exercise | Option to Purchase Common Stock | 5,000 footnote F1 | $0.00 | - | ||
| Option exercise | Option to Purchase Common Stock | 1,000 footnote F2 | $0.00 | - | ||
| ||||||
| Brian F. Kidd - Officer | Option exercise | Common Stock | 4,000 footnote F1 | $94.10 | $376K | |
| Brian F. Kidd - Officer | Option exercise | Common Stock | 500 footnote F2 | $90.62 | $45K | |
| Brian F. Kidd - Officer | Tax withholding / forfeiture | Common Stock | 3,134 footnote F3 | $197.96 | $620K | |
| Brian F. Kidd - Officer | Option exercise | Option to Purchase Common Stock | 4,000 footnote F1 | $0.00 | - | |
| Brian F. Kidd - Officer | Option exercise | Option to Purchase Common Stock | 500 footnote F2 | $0.00 | - | |
| ||||||
| Sandra Y. Trail - Director | Option exercise | Shares of Common Stock | 3,140 footnote F1 | $55.75 | $175K | |
| Sandra Y. Trail - Director | Option exercise | Option to Purchase Common Stock [2023 Grant] | 3,140 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Option to Purchase Common Stock [2026 Grant] | 7,500 | $0.00 | - | ||
| Sandra Y. Trail - Director | Grant or award | Option to Purchase Common Stock [2026 Grant] | 7,500 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Option to Purchase Common Stock [2026 Grant] | 7,500 footnote F1 | $0.00 | - | ||
| ||||||
| Grant or award | Option to Purchase Common Stock [2026 Grant] | 7,500 footnote F1 | $0.00 | - | ||
| ||||||
| Grant or award | Option to Purchase Common Stock [2026 Grant] | 7,500 footnote F1 | $0.00 | - | ||
| ||||||
| Lisa Piercey - Director | Grant or award | Option to Purchase Common Stock [2026 Grant] | 7,500 footnote F1 | $0.00 | - | |
| ||||||
| Robert G. Adams - Director | Grant or award | Option to Purchase Common Stock [2026 Grant] | 7,500 footnote F1 | $0.00 | - | |
| ||||||
| Emil E. Hassan - Director | Grant or award | Option to Purchase Common Stock [2026 Grant] | 7,500 footnote F1 | $0.00 | - | |
| ||||||
| Richard F. Laroche Jr. - Director | Grant or award | Option to Purchase Common Stock [2026 Grant] | 7,500 footnote F1 | $0.00 | - | |
| ||||||
| Richard F. Laroche Jr. - Director | Option exercise | Option to Purchase Common Stock [2021 Grant] | 7,500 footnote F1 | $0.00 | - | |
| Richard F. Laroche Jr. - Director | Option exercise | Common Stock - Held in my name or my wife's name | 7,500 footnote F1 | $71.64 | $537K | |
| ||||||
Recent NHC Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| McCreary Josh A | Officer | 2,719 | $601K | View on EDGAR | |
| - | - | - | - |
NHC insider trading FAQ
What is the latest insider trade for NHC?
NATIONAL HEALTHCARE CORP (NHC) had 8 insider filings in the last 90 days, with the most recent on 2026-09-23. The full record for NHC runs to 89 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NHC stock?
No insider purchases of NHC were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling NHC stock?
15 insider sales of NHC were filed in the last 90 days, totaling $5.58M.
Where can I see NHC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NHC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Vicki L. Dodson view on EDGAR
- - Josh A. McCreary view on EDGAR
- - Brian F. Kidd view on EDGAR
- - Ben Anderson Flatt Sr. view on EDGAR
- - David R. Gifford view on EDGAR
- - David R. Gifford view on EDGAR
- - Stephen Fowler Flatt view on EDGAR
- - David R. Gifford view on EDGAR
- - Emil E. Hassan view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NHC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NHC with a 7-day demo
- NHC on your watchlist
- Every NHC Form 4 filing on record
- Up to 3 months of NHC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive